News

Distinct markers found in the blood of people with coeliac disease could lead to a world-first blood test for diagnosing patients after one small meal of gluten.

A new genomics module has been created in the Irish National Epilepsy Electronic Patient Record (EPR) system. The work illustrates how an electronic health system can support the integration of genomic test results and new genetic knowledge into routine clinical care in the public health system.

Differences in how our brains respond when we're anticipating a financial reward are due, in part, to genetic differences, according to research with identical and fraternal twins. The findings suggest that how we experience pleasure and reward is at least partly heritable.

Researchers have identified immune cells that help reduce the severity of a disease in mice akin to multiple sclerosis. These cells could one day be useful therapeutic targets in treating autoimmune diseases.

Scientists at the German Center for Neurodegenerative Diseases (DZNE) have identified a group of proteins that help to regenerate damaged nerve cells. Their findings are reported in the journal Neuron.

Researchers have developed a way to use immunotherapy drugs against treatment-resistant non-Hodgkin’s lymphomas for the first time by combining them with stem cell transplantation, an approach that also dramatically increased the success of the drugs in melanoma and lung cancer.

A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression.

The fight against cystic fibrosis continues. A research team was able to prove the efficacy of Crispr-Cas, the molecular scissors it has been working on for some time, in solving once and for all the problem that causes the disease.

Rice University researchers are configuring layered filter paper to mimic aortic heart valves. The technique allows researchers to study in detail how calcifying diseases slow or stop hearts from functioning.

Researchers used multi-spectral, high-resolution two-photon microscopy to literally watch potential synapses come and go in the visual cortex of mice - both in the light, or normal visual experience, and in the darkness, where there is no visual input. By comparing observations made in normal mice and ones engineered to lack CPG15, they were able to show that the protein is required in order for visual experience to facilitate the transition of nascent excitatory synapses to permanence.